Aerovate Therapeutics Files 8-K Report
Ticker: JBIO · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1798749
| Field | Detail |
|---|---|
| Company | Aerovate Therapeutics, INC. (JBIO) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: AVTE
TL;DR
AVTE filed an 8-K on 4/23 for 'Other Events' - details TBD.
AI Summary
On April 23, 2025, Aerovate Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." No specific details regarding new events, material agreements, or financial transactions were disclosed in the provided excerpt.
Why It Matters
This filing signifies an update from Aerovate Therapeutics to the SEC, though the specific nature of the 'Other Events' requires further investigation beyond this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for 'Other Events' and does not contain specific material information that would immediately impact risk.
Key Players & Entities
- Aerovate Therapeutics, Inc. (company) — Registrant
- 0001798749 (company) — Central Index Key
- 001-40544 (company) — SEC File Number
- 831377888 (company) — EIN
- April 23, 2025 (date) — Date of Report
- 930 Winter Street, Suite M-500, Waltham, Massachusetts 02451 (location) — Business Address
FAQ
What specific 'Other Events' are being reported by Aerovate Therapeutics, Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not specify the details of the 'Other Events'.
When was this 8-K report filed by Aerovate Therapeutics, Inc.?
The report was filed on April 23, 2025.
What is the Central Index Key (CIK) for Aerovate Therapeutics, Inc.?
The CIK for Aerovate Therapeutics, Inc. is 0001798749.
What is the SEC File Number for Aerovate Therapeutics, Inc.?
The SEC File Number for Aerovate Therapeutics, Inc. is 001-40544.
Where is Aerovate Therapeutics, Inc. headquartered?
Aerovate Therapeutics, Inc. is headquartered at 930 Winter Street, Suite M-500, Waltham, Massachusetts 02451.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Aerovate Therapeutics, Inc. (JBIO).